產品名稱：CHO/dhFr-二氫還原酶缺陷型中國倉鼠卵巢細胞、CHO/dhFr-二氫還原酶缺陷型中國倉鼠卵巢細胞、CHO/dhFr-二氫還原酶缺陷型中國倉鼠卵巢細胞、CHO/dhFr-二氫還原酶缺陷型中國倉鼠卵巢細胞

FDA-approved drugs for neoplasms and FDA-approved therapies at the FDA website was performed. An initial literature review was based on the American Association for Clinical Research meeting 2019, the American Society of Clinical Oncology meeting 2019 and the European Society of Medical Oncology 2019 proceedings. A systematic search of PubMed was performed involving MeSH browser terms such as biomarkers, immunotherapy, gastrointestinal